ctrl K

Price Alert

Kiniksa Pharmaceuticals L... (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

33.26

-0.02 (-0.06%)

At close: Aug 15, 2025, 3:05 PM

Kiniksa Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	183.58M	107.95M	122.72M	122.47M
Short-Term Investments	60.05M	98.42M	67.89M	59.73M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	10.31M	827K	5.82M	8.72M
Receivables	41.72M	21.27M	20.32M	3.98M
Inventory	26.36M	31.12M	21.6M	3.67M
Other Current Assets	20.08M	17.54M	10.54M	6.58M
Total Current Assets	331.8M	276.3M	243.06M	196.45M
Property-Plant & Equipment	11.04M	12.66M	7.04M	8.38M
Goodwill & Intangibles	16.25M	17.25M	18.25M	19.25M
Total Long-Term Assets	248.75M	250.03M	216.61M	36.35M
Total Assets	580.55M	526.32M	459.67M	232.8M
Account Payables	2.04M	8.25M	7.9M	1.87M
Deferred Revenue	n/a	307K	12M	38.03M
Short-Term Debt	n/a	n/a	3.3M	3.38M
Other Current Liabilities	96.59M	36.91M	21.35M	7.08M
Total Current Liabilities	100.62M	63.67M	47.07M	44.82M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	41.5M	1.86M	1.84M	270K
Total Long-Term Liabilities	41.5M	23.82M	16.46M	2.94M
Total Liabilities	142.12M	87.48M	63.52M	47.76M
Total Debt	9.86M	12.26M	5.92M	6.05M
Common Stock	20K	20K	19K	18K
Retained Earnings	-521.14M	-477.95M	-492.03M	-675.4M
Comprehensive Income	-163K	6K	44K	-66K
Shareholders Equity	438.44M	438.84M	-492.03M	-675.4M
Total Investments	60.05M	98.42M	67.89M	59.73M